Nontoxic membrane translocation peptide from protamine, low molecular weight protamine (LMWP), for enhanced intracellular protein delivery: in vitro and in vivo study

Wiley - Tập 19 Số 11 - Trang 1555-1557 - 2005
Yoon Jeong Park1, Li‐Chien Chang2, Jun F. Liang3, Cheol Moon4, Chong‐Pyoung Chung5, Victor C. Yang4
1Craniomaxillofacial Reconstructive Science Major School of Dentistry Intellectual Biointerface Engineering Center Seoul National University Seoul South Korea
2School of PharmacyNational Defense Medical Center Taipei Taiwan
3Department of Chemistry and Chemical Biology, Stevens Institute of Technology, Hoboken, New Jersey, USA.
4College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA
5Department of Periodontology School of Dentistry Intellectual Biointerface Engineering Center Seoul National University Seoul South Korea

Tóm tắt

ABSTRACTNaturally derived, nontoxic peptides from protamine by the authors, termed low molecular weight protamines (LMWPs), possess high arginine content and carry significant sequence similarity to that of TAT, by far the most potent protein transduction domain peptide. Therefore, it was hypothesized that these LMWPs would also inherit the similar translocation activity across the cell membrane, which enables any impermeable species to be transduced into the cells. LMWPs were prepared by enzymatic digestion of protamine, examined their capability of transducing an impermeable protein toxin into the tumor cells by chemical conjugation, and determined cytotoxicity of transduced protein toxin (e.g., gelonin) against cancer cell lines and a tumor‐bearing mouse. In vitro results showed that LMWPs could indeed translocate themselves into several mammalian cell lines as efficiently as TAT, thereby transducing impermeable gelonin into the cells by chemical conjugation. In vivo studies further confirmed that LMWP could carry an impermeable gelonin across the tumor mass and subsequently inhibit the tumor growth. In conclusion, the presence of equivalent cell translocation potency, absence of toxicity of peptide itself, and the suitability for low‐cost production by simple enzymatic digestion could expand the range of clinical applications of LMWPs, including medical imaging and gene/protein therapies.

Từ khóa


Tài liệu tham khảo

10.1073/pnas.91.2.664

Snyder E. L., 2001, Protein/peptide transduction domains: potential to deliver large DNA molecules into cells, Curr. Opin. Mol. Ther., 3, 147

10.1002/j.1460-2075.1991.tb07697.x

10.1073/pnas.88.5.1864

10.1016/S0092-8674(00)81843-7

10.1074/jbc.272.25.16010

Schwartz S. R., 1999, In vivo protein transduction: delivery of a biologically active protein into the mouse, Science, 285, 1569, 10.1126/science.285.5433.1569

10.1021/bc980125h

10.1038/74464

Torchilin V. P., 2001, TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors, Proc. Natl. Acad. Sci. USA, 798, 8786, 10.1073/pnas.151247498

10.1021/bc025517

10.1074/jbc.M007540200

10.1016/S0049-3848(98)00201-1

10.1208/ps030317

Chang L. C., 2001, Low molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (II): in vitro evaluation of efficacy and toxicity, AAPS PharmSci., 3

Lee L. M., 2001, Low molecular weight protamine as nontoxic heparin/low molecular weight heparin antidote (III): preliminary in vivo evaluation of efficacy and toxicity using a canine model, AAPS PharmSci., 3

10.1016/S0049-3848(00)00427-8

10.1023/A:1022109905487

10.1002/jgm.402

10.1042/bj1730723

10.1016/0304-4165(92)90022-M

10.1146/annurev.cellbio.12.1.575

10.1038/nbt1201-1173

10.1016/S0968-0896(02)00248-1

10.1016/S0006-291X(03)01167-7

10.1021/jm0105676

10.1073/pnas.122157899

10.1002/1097-0215(20010601)92:5<761::AID-IJC1238>3.0.CO;2-4

Rosenblum M. G., 1999, Recombinant immunotoxins directed against the c‐erb‐2/HER2/neu oncogen product: in vitro cytotoxicity, pharmacokinetics and in vivo efficacy studies in xenograft models, Clin. Cancer Res., 5, 865

10.1038/4042

McGrath M. S., 2003, Immunotoxin resistance in multidrug resistant cells, Cancer Res., 63, 72

10.1073/pnas.97.24.13003

10.1074/jbc.M110017200

Thông tin
Thông tin xuất bản

Wiley

Tập 19 Số 11

1555-1557

Thông tin tác giả